Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Philips Health Technology Ventures

Investor type Venture Capital
Founders Lara Koole Nicholas A. Pappas Richard Wilmot

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 6
Average round size
info
The average size of a deal this fund participated in
$8M
Portfolio companies 2
Rounds per year 0.25
Lead investments 3
Key employees 1

Areas of investment

  • Health Care
  • Apps
  • Messaging
  • Information Technology
  • Medical
Summary

The main office of represented VC is situated in the Drenthe. The fund was located in Europe if to be more exact in The Netherlands.

The fund has exact preference in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Mytonomy, LeQuest For fund there is a match between the country of its foundation and the country of its the most frequent investments - The Netherlands. Among the most successful fund investment fields, there are Medical, Wellness.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Philips Health Technology Ventures, startups are often financed by NewSchools Venture Fund, Kapor Capital, imec.istart. The meaningful sponsors for the fund in investment in the same round are Vesalius Biocapital Partners, PMV, Noaber.

The fund was created by Lara Koole, Nicholas A. Pappas, Richard Wilmot. We also calculated 1 valuable employee in our database.

The usual things for fund are deals in the range of 5 - 10 millions dollars. The real fund results show that this VC is 55 percentage points more often commits exit comparing to other companies. The high activity for fund was in 2019. The fund is constantly included in less than 2 investment rounds annually.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
ACH Worldwid -
Allegis NL Capital -
aSTART Chiyoda, Japan
Enterprise Holdings Missouri, St Louis, United States
eYantra Industries Andhra Pradesh, Hyderabad, India
Food AFrica Accelerator Kenya, Nairobi, Nairobi Area
FUTURE NETWORK China, Jiangsu, Nanjing
Gratyo Universal Indonesia -
Hamilton Lane Bala Cynwyd, Pennsylvania, United States
Investment Partners of Orlando Florida, Orlando, United States
IT PROPARTNERS Japan, Kanagawa Prefecture, Kawasaki
Koramco Seoul, Seoul-t'ukpyolsi, South Korea
Letterone Holdings SA -
Menora Mivtachim -
New England Patriots Foxboro, Massachusetts, United States
New Oriental Education & Technology Beijing, China, Haidian
ShakeUpFactory France, Ile-de-France, Paris
Sorfina Capital Houston, Texas, United States
Thrive Partners -
Zhongyixin Touzi China, Futian, Guangdong

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Moving Analytics

Health Care
Information Technology
Medical
mHealth
$20M08 Jul 2022 Los Angeles, California, United States

Siilo

Apps
Health Care
Messaging
$11M30 Jul 2020 Amsterdam, North Holland, Netherlands
News
Carevive Closes Oversubscribed $18M Series C Equity Raise

– Carevive Systems (Carevive), the leading oncology-focused health technology company centered on understanding and improving the cancer patient experience, has today announced the completion of a Series C equity investment of $18 million.
– The oversubscribed $18 million equity round was led by Philips Health Technology Ventures, and also includes Debiopharm Innovation Fund, and OurCrowd’s digital health fund, Qure Ventures, as well as prior investors HLM Venture Partners, LRVHealth, Cerner, and founder Madelyn Trupkin Herzfeld.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Philips Health Technology Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: